Global /China /Healthcare /Drug Manufacturers - General /300436

Fujian Cosunter Pharmaceutical Co., Ltd.

300436

• SHE: 300436 • Delayed

117.30CNY 0.4%

17.32 USD

As of 7 June 2026, Fujian Cosunter Pharmaceutical Co., Ltd. has a market cap of $2.75B USD, ranking #5774 globally and #1281 in China. It ranks #453 in the Healthcare sector, and #178 in the Drug Manufacturers - General industry.

Global Rank

5774

Country Rank

1281

Sector Rank

453

Industry Rank

178

Key Stats

Market Cap

$2.75BUSD

18.6B CNY

Enterprise Value

$2.8BUSD

18.95B CNY

Revenue (TTM)

$61.63MUSD

417.21M CNY

EBITDA (TTM)

$786.39KUSD

5.33M CNY

Net Income (TTM)

-$31.8MUSD

-215.28M CNY

EBITDA Margin

1.3%

Profit Margin

-52%

PS Ratio

44.6

PB Ratio

58.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Guoping Li open_in_new

Employees

760

Founded

2001

Website

cosunter.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	-0.4%	15%	11%	5.3%	33%	305%	274%	240%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300436 福建广生堂药业股份有限公司 Class A ISIN: CNE100001YZ0 Shares Out.: Shares Outstanding: 159.267M¹ Shares Float: 114.197M² TV: TradingView: SZSE: 300436 SA: Stock Analysis: SHE: 300436 YF: Yahoo Finance: 300436.SZ GF: Google Finance: SHE: 300436 BA: Barron's: 300436 MS: Morningstar: XSHE: 300436	117.30 CNY	TV: TradingView: SZSE: 300436 SA: Stock Analysis: SHE: 300436 YF: Yahoo Finance: 300436.SZ GF: Google Finance: SHE: 300436 BA: Barron's: 300436 MS: Morningstar: XSHE: 300436

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Fujian Cosunter Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.9B 364.89B CNY 2K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.69B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 938%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 584%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 501%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 483%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 28K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 20K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 13K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 12K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 10K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 10K%	20.5	Switzerland

chevron_leftBack